超小微囊在淋巴管肌瘤病中损害弥散功能但不阻塞气流
该研究纳入103例LAM患者,同次就诊完成肺功能检查与CT检查,用FDA批准的商用软件测量囊腔评分(囊腔占肺体积百分比)。实验性超高分辨率区域CT额外发现的囊腔体积平均直径2.2±0.8mm,称为「超小微囊组分」,占总囊腔体积27.9±19.0%。校正人口学变量后,全肺囊腔评分更好地解释DLCO(%预计值)的变异(P<.001,经多重比较校正),但不能解释FEV1及FEV1/FVC的变异(P=1.00);超小微囊组分贡献DLCO下降(P<.001),对FEV1及FEV1/FVC无贡献(P=.760和.575)。提示超小微囊主要损害弥散功能,气流阻塞不明显。
要点
- 超小微囊(平均直径2.2±0.8mm)占总囊腔体积27.9±19.0%,主要与DLCO(%预计值)下降相关(P<.001)。
- 全肺囊腔评分可解释DLCO变异(P<.001,经多重比较校正),但不能解释FEV1及FEV1/FVC变异(P=1.00)。
- 超小微囊组分对FEV1及FEV1/FVC无显著贡献(P=.760和.575)。
- 囊腔负荷较低、FEV1及FEV1/FVC较好的患者,平均囊腔尺寸趋于更小、超小微囊组分更高。
- 标准CT可能低估超小微囊负荷,需实验性超高分辨率CT才能识别这部分囊腔。
适用人群与场景
- 103例淋巴管肌瘤病(LAM)患者,同次就诊完成肺功能检查与CT检查。
- LAM主要见于育龄期女性,以含气囊腔形成为特征。
诊断标准与关键阈值
- 囊腔评分:囊腔占肺体积的百分比,由美国食品药品监督管理局批准的商用软件测量。
- 超小微囊组分:实验性超高分辨率区域CT额外识别的囊腔体积,平均直径2.2±0.8mm。
- 肺功能指标:DLCO(%预计值)、FEV1(%预计值)、FEV1/FVC(%预计值)。
研究设计与关键结果
- 研究设计:103例LAM患者同次就诊接受肺功能检查与CT检查,分析囊腔评分与肺功能指标的关联,校正人口学变量。
- 超小微囊(平均直径2.2±0.8mm)占总囊腔体积27.9±19.0%。
- 全肺囊腔评分更好地解释DLCO(%预计值)的变异(P<.001,经多重比较校正),但不能解释FEV1及FEV1/FVC的变异(P=1.00)。
- 超小微囊组分贡献DLCO下降(P<.001),对FEV1无贡献(P=.760),对FEV1/FVC无贡献(P=.575)。
- 超小微囊组分和平均囊腔尺寸与囊腔负荷、FEV1及FEV1/FVC相关,与DLCO相关性较弱。
- 囊腔负荷较低、FEV1及FEV1/FVC较好的患者,平均囊腔尺寸趋于更小、超小微囊组分更高。
证据类型、等级与局限
- 证据类型:横断面研究(103例LAM患者同次就诊完成肺功能与CT检查)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,超小微囊主要贡献DLCO下降,对FEV1及FEV1/FVC影响极小。
- 作者认为,囊腔负荷较低且FEV1、FEV1/FVC较好的患者,平均囊腔尺寸趋于更小、超小微囊组分更高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare lung disease found primarily in women of childbearing age, characterized by the formation of air-filled cysts, which may be associated with reductions in lung function. An experimental, regional ultra-high resolution CT scan identified an additional volume of cysts relative to standard chest CT imaging, which consisted primarily of ultra-small cysts.
RESEARCH QUESTION: What is the impact of these ultra-small cysts on the pulmonary function of patients with LAM?
STUDY DESIGN AND METHODS: A group of 103 patients with LAM received pulmonary function tests and a CT examination in the same visit. Cyst score, the percentage lung volume occupied by cysts, was measured by using commercial software approved by the US Food and Drug Administration. The association between cyst scores and pulmonary function tests of diffusing capacity of the lungs for carbon monoxide (Dlco) (% predicted), FEV1 (% predicted), and FEV1/FVC (% predicted) was assessed with statistical analysis adjusted for demographic variables. The distributions of average cyst size and ultra-small cyst fraction among the patients were evaluated.
RESULTS: The additional cyst volume identified by the experimental, higher resolution scan consisted of cysts of 2.2 ± 0.8 mm diameter on average and are thus labeled the "ultra-small cyst fraction." It accounted for 27.9 ± 19.0% of the total cyst volume among the patients. The resulting adjusted, whole-lung cyst scores better explained the variance of Dlco (P < .001 adjusted for multiple comparisons) but not FEV1 and FEV1/FVC (P = 1.00). The ultra-small cyst fraction contributed to the reduction in Dlco (P < .001) but not to FEV1 and FEV1/FVC (P = .760 and .575, respectively). The ultra-small cyst fraction and average cyst size were correlated with cyst burden, FEV1, and FEV1/FVC but less with Dlco.
INTERPRETATION: The ultra-small cysts primarily contributed to the reduction in Dlco, with minimal effects on FEV1 and FEV1/FVC. Patients with lower cyst burden and better FEV1 and FEV1/FVC tended to have smaller average cyst size and higher ultra-small cyst fraction.
CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT00001465; URL: www.clinicaltrials.gov.
参考来源
- Matthew BP, Hasani AM, Chen YC, et al. Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis. Chest. 2021. PMID: 33549601. doi:10.1016/j.chest.2021.01.077
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。